Symptom Adapted Therapy in GERD Patients

NCT00343161 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: esomeprazole
DRUG: Gelusil-Lac (Aluminum hydroxide gel,magnesium trisilicate)

Sponsor

AstraZeneca